Page last updated: 2024-10-22

amantadine and Helicobacter Infections

amantadine has been researched along with Helicobacter Infections in 1 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ahmed, A1
Saeed, A1
Ali, OM1
El-Bahy, ZM1
Channar, PA1
Khurshid, A1
Tehzeeb, A1
Ashraf, Z1
Raza, H1
Ul-Hamid, A1
Hassan, M1

Other Studies

1 other study available for amantadine and Helicobacter Infections

ArticleYear
Exploring Amantadine Derivatives as Urease Inhibitors: Molecular Docking and Structure-Activity Relationship (SAR) Studies.
    Molecules (Basel, Switzerland), 2021, Nov-25, Volume: 26, Issue:23

    Topics: Amantadine; Catalytic Domain; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Human

2021